Associate Director, Oncology Treatment Journey & Process Design

Merck & Co.; United States; Remote; USD 157,000 - 247,000; Full time

Job summary

Merck & Co. in the United States is seeking a senior commercial operations leader to design and integrate the operational processes for the Intismeran treatment journey, coordinating across sites, labs, sequencing, manufacturing, and partners to enable scalable delivery.

Reporting to the Director, Individualized Therapy Operations, you will drive governance, continuous improvement, and collaboration with IT to evolve orchestration platforms, ensuring alignment with launch readiness and patient

Qualifications

• Minimum of 5 years of experience in pharmaceutical, biotechnology, or healthcare industries.
• Experience designing cross-functional operating models coordinating internal functions and external partners.
• Ability to lead cross-functional initiatives and influence stakeholders.

Responsibilities

• Design end-to-end treatment journey process architecture.
• Be commercial owner for treatment journey workflows and requirements.
• Drive process integration across the operational ecosystem.
• Establish governance, escalation pathways, and issue resolution processes.
• Partner with IT to optimize site experiences and digital solutions.
• Lead continuous improvement across the ecosystem.
• Collaborate with Digital/IT to evolve orchestration platform capabilities.

Skills

Adaptability

Process design

Campaign management

Data analysis

Market research

Operations management

People leadership

External partners

Education

Bachelor's degree

MBA

Job description

Merck & Co. in the United States is seeking a senior commercial operations leader to design and integrate the operational processes for the Intismeran treatment journey, coordinating across sites, labs, sequencing, manufacturing, and partners to enable scalable delivery.

Reporting to the Director, Individualized Therapy Operations, you will drive governance, continuous improvement, and collaboration with IT to evolve orchestration platforms, ensuring alignment with launch readiness and patient